The capital raise also needs shareholder approval. A capital raise may get approved with some adjustments. Issuing Options may not be part of the deal. If the company is going to increase revenues Options aren't a good idea, more dilutive.
The contingency to adjust the price down may have been due to the possibility of the FDA Approval being delayed. It was expected in March.
The capital raise also needs shareholder approval. A capital...
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.74M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 13.0¢ | $6.028K | 46.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 281586 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 154604 | 3 |
View Market Depth
| Last trade - 12.49pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
13.0¢ |
Change
0.000 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 13.5¢ | 13.5¢ | 13.0¢ | 18031 | ||
| Last updated 12.49pm 13/05/2024 ? | |||||
| UBI (ASX) Chart |